Baker Avenue Asset Management, LP Amgen Inc Transaction History

Baker Avenue Asset Management, LP

  • $5.03 Billion
  • Q3 2025

A detailed history of Baker Avenue Asset Management, LP transactions in Amgen Inc stock. As of the latest transaction made, Baker Avenue Asset Management, LP holds 14,659 shares of AMGN stock, worth $4.96 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares
14,659
Previous 14,713 0.37%
Holding current value
$4.96 Million
Previous $4.11 Million 0.68%
% of portfolio
0.08%
Previous 0.11%

Shares

33 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 30, 2025
SELL
$271.18 - $309.22 $14,643 - $16,697
-54 Reduced 0.37%
14,659 $4.14 Million
Q2 2025

Aug 13, 2025
BUY
$262.28 - $309.85 $644,946 - $761,921
2,459 Added 20.07%
14,713 $4.11 Million
Q1 2025

May 08, 2025
BUY
$258.59 - $327.36 $2.31 Million - $2.92 Million
8,934 Added 269.1%
12,254 $3.82 Million
Q4 2024

Feb 14, 2025
BUY
$258.78 - $328.31 $27,948 - $35,457
108 Added 3.36%
3,320 $865,000
Q3 2024

Nov 01, 2024
BUY
$309.38 - $337.38 $514,189 - $560,725
1,662 Added 107.23%
3,212 $1.03 Million
Q2 2024

Aug 07, 2024
BUY
$262.75 - $319.31 $18,392 - $22,351
70 Added 4.73%
1,550 $484,000
Q1 2024

May 10, 2024
BUY
$268.87 - $324.56 $4,301 - $5,192
16 Added 1.09%
1,480 $420,000
Q4 2023

Feb 13, 2024
BUY
$255.7 - $288.46 $1,534 - $1,730
6 Added 0.41%
1,464 $421,000
Q3 2023

Nov 14, 2023
BUY
$218.65 - $271.46 $15,086 - $18,730
69 Added 4.97%
1,458 $391,000
Q2 2023

Aug 11, 2023
SELL
$214.27 - $253.37 $10,927 - $12,921
-51 Reduced 3.54%
1,389 $308,000
Q1 2023

May 15, 2023
SELL
$225.79 - $275.2 $677 - $825
-3 Reduced 0.21%
1,440 $348,000
Q4 2022

Feb 13, 2023
SELL
$229.03 - $291.01 $46,264 - $58,784
-202 Reduced 12.28%
1,443 $378,000
Q3 2022

Nov 14, 2022
BUY
$224.46 - $253.15 $30,526 - $34,428
136 Added 9.01%
1,645 $371,000
Q2 2022

Aug 03, 2022
BUY
$230.71 - $256.74 $112,586 - $125,289
488 Added 47.8%
1,509 $367,000
Q1 2022

May 16, 2022
SELL
$219.27 - $242.57 $228,040 - $252,272
-1,040 Reduced 50.46%
1,021 $247,000
Q4 2021

Feb 11, 2022
BUY
$198.88 - $227.6 $50,913 - $58,265
256 Added 14.18%
2,061 $464,000
Q3 2021

Nov 15, 2021
BUY
$212.27 - $248.7 $200,170 - $234,524
943 Added 109.4%
1,805 $383,000
Q2 2021

Aug 16, 2021
SELL
$233.58 - $259.14 $5,605 - $6,219
-24 Reduced 2.71%
862 $210,000
Q4 2020

Feb 17, 2021
SELL
$216.38 - $257.67 $4.49 Million - $5.35 Million
-20,769 Reduced 95.91%
886 $203,000
Q3 2020

Nov 16, 2020
BUY
$234.65 - $260.95 $80,954 - $90,027
345 Added 1.62%
21,655 $5.5 Million
Q2 2020

Aug 12, 2020
SELL
$197.81 - $242.74 $321,441 - $394,452
-1,625 Reduced 7.09%
21,310 $5.03 Million
Q1 2020

May 14, 2020
SELL
$182.24 - $241.7 $1.93 Million - $2.55 Million
-10,567 Reduced 31.54%
22,935 $4.65 Million
Q4 2019

Feb 14, 2020
SELL
$189.21 - $243.2 $214,564 - $275,788
-1,134 Reduced 3.27%
33,502 $8.08 Million
Q3 2019

Nov 15, 2019
SELL
$174.11 - $208.62 $268,651 - $321,900
-1,543 Reduced 4.26%
34,636 $6.7 Million
Q2 2019

Aug 14, 2019
SELL
$166.7 - $195.41 $193,705 - $227,066
-1,162 Reduced 3.11%
36,179 $6.67 Million
Q1 2019

May 15, 2019
SELL
$180.87 - $203.88 $157,718 - $177,783
-872 Reduced 2.28%
37,341 $7.09 Million
Q4 2018

Feb 14, 2019
SELL
$178.4 - $208.25 $81,885 - $95,586
-459 Reduced 1.19%
38,213 $7.44 Million
Q3 2018

Nov 15, 2018
BUY
$185.29 - $208.89 $281,084 - $316,886
1,517 Added 4.08%
38,672 $8.02 Million
Q2 2018

Aug 14, 2018
BUY
$166.05 - $186.51 $135,330 - $152,005
815 Added 2.24%
37,155 $6.86 Million
Q1 2018

May 15, 2018
BUY
$169.43 - $198.0 $6,777 - $7,920
40 Added 0.11%
36,340 $6.2 Million
Q4 2017

Feb 14, 2018
BUY
$168.79 - $188.59 $372,013 - $415,652
2,204 Added 6.46%
36,300 $6.31 Million
Q3 2017

Nov 14, 2017
BUY
$167.29 - $191.0 $158,758 - $181,259
949 Added 2.86%
34,096 $6.36 Million
Q2 2017

Aug 11, 2017
BUY
N/A
33,147
33,147 $5.71 Million

Others Institutions Holding AMGN

# of Institutions
3,286
Shares Held
433M
Call Options Held
6.16M
Put Options Held
7.07M
View Full List

About AMGEN INC

AMGN Quotes by TradingView
  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $181B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Baker Avenue Asset Management, LP Portfolio

Follow Baker Avenue Asset Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Baker Avenue Asset Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Baker Avenue Asset Management, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email